GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Gross Margin %

PharmX Technologies (ASX:PHX) Gross Margin % : 80.59% (As of Dec. 2023)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. PharmX Technologies's Gross Profit for the six months ended in Dec. 2023 was A$2.53 Mil. PharmX Technologies's Revenue for the six months ended in Dec. 2023 was A$3.14 Mil. Therefore, PharmX Technologies's Gross Margin % for the quarter that ended in Dec. 2023 was 80.59%.

Warning Sign:

PharmX Technologies Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.5%.


The historical rank and industry rank for PharmX Technologies's Gross Margin % or its related term are showing as below:

ASX:PHX' s Gross Margin % Range Over the Past 10 Years
Min: 67.19   Med: 88   Max: 89.49
Current: 67.19


During the past 13 years, the highest Gross Margin % of PharmX Technologies was 89.49%. The lowest was 67.19%. And the median was 88.00%.

ASX:PHX's Gross Margin % is ranked better than
75.53% of 609 companies
in the Healthcare Providers & Services industry
Industry Median: 41.4 vs ASX:PHX: 67.19

PharmX Technologies had a gross margin of 80.59% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for PharmX Technologies was -1.50% per year.


PharmX Technologies Gross Margin % Historical Data

The historical data trend for PharmX Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Gross Margin % Chart

PharmX Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.73 86.80 84.76 88.27 79.89

PharmX Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.40 90.21 86.67 695.52 80.59

Competitive Comparison of PharmX Technologies's Gross Margin %

For the Health Information Services subindustry, PharmX Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's Gross Margin % falls into.



PharmX Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

PharmX Technologies's Gross Margin for the fiscal year that ended in Jun. 2023 is calculated as

Gross Margin % (A: Jun. 2023 )=Gross Profit (A: Jun. 2023 ) / Revenue (A: Jun. 2023 )
=4.8 / 6.018
=(Revenue - Cost of Goods Sold) / Revenue
=(6.018 - 1.21) / 6.018
=79.89 %

PharmX Technologies's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=2.5 / 3.142
=(Revenue - Cost of Goods Sold) / Revenue
=(3.142 - 0.61) / 3.142
=80.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PharmX Technologies  (ASX:PHX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PharmX Technologies had a gross margin of 80.59% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


PharmX Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies (ASX:PHX) Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.